Zicam Cold Remedy Gel
NDC Package 10237-472-22

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Zicam Cold Remedy (galphimia glauca flowering top, luffa operculata fruit, and schoenocaulon officinale seed) gel is for best results, use at the first sign of a cold and continue to use until symptoms completely subsideadults and children 12 years of age and older: open tube (also see illustration on side of carton)hold tube between thumb and forefinger at the blue bandwith other hand, hold at handle base, snap open tube and pull out swabapply medication just inside first nostril. This formulation utilizes a gel delivery system. Marketed by Church & Dwight Co., Inc., this product is identified by NDC 10237-472.

Identification & Billing

NDC Package Code
10237-472-22
Package Description
2 CARTON in 1 PACKAGE / 20 TUBE, WITH APPLICATOR in 1 CARTON / 1.2 mL in 1 TUBE, WITH APPLICATOR
Product Code
10237-472
11-Digit Billing Format
10237047222

Clinical Specifications

Proprietary Name
Zicam Cold Remedy
Non-Proprietary Name
Galphimia Glauca Flowering Top, Luffa Operculata Fruit, And Schoenocaulon Officinale Seed
Substance Name
Galphimia Glauca Flowering Top; Luffa Operculata Fruit; Schoenocaulon Officinale Seed
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
Usage Information
For best results, use at the first sign of a cold and continue to use until symptoms completely subsideadults and children 12 years of age and older: open tube (also see illustration on side of carton)hold tube between thumb and forefinger at the blue bandwith other hand, hold at handle base, snap open tube and pull out swabapply medication just inside first nostril. Using swirling motion, rotate swab 3 times within nostril. While swirling, gently press outside of first nostril to ensure transfer of medication. Re-dip swab in tube and mix to re-saturate with medication. Swirl 3 more times in the same nostril while gently pressing outside of nostril. Re-dip swab in tube and mix. Repeat identical sequence in second nostril. Do not insert swab more than 1/4" past nasal opening.discard swab after usewait at least 30 seconds before blowing noseuse 1 tube every 3 hours, not to exceed 5 tubes in one 24 hour periodchildren under 12 years of age: do not use

Regulatory & Marketing

Labeler Name
Church & Dwight Co., Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
02-28-2022
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (10237-472). Click a package code to view its specific billing and regulatory data.

10237-472-20
20 TUBE, WITH APPLICATOR in 1 CARTON / 1.2 mL in 1 TUBE, WITH APPLICATOR

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10237-472-22 identifies a specific commercial package of 2 carton in 1 package / 20 tube, with applicator in 1 carton / 1.2 ml in 1 tube, with applicator of Zicam Cold Remedy, a human over the counter drug labeled by Church & Dwight Co., Inc.. This gel is formulated for nasal use and contains galphimia glauca flowering top; luffa operculata fruit; schoenocaulon officinale seed as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Church & Dwight Co., Inc. on February 28, 2022. The current certification is valid through December 31, 2027.

How is this Church & Dwight Co., Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10237047222. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
10237-472-22
11-Digit CMS (5-4-2)
10237-0472-22

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.